To investigate the effect of aromatherapy on reperfusion injury protection and long-term prognosis after STEMI intervention: a prospective, randomized controlled study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003213

Enrollment

Unknown

Registered

2020-04-15

Start date

2020-05-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

experimental group:Kuanxiong Aerosol

control group:placebo

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in the study and sign the informed consent; 2. Patients with acute ST elevation myocardial infarction; 3. Direct PCI indications; 4. Aged 20 to 80 years.

Exclusion criteria

Exclusion criteria: 1. Chest pain symptoms > for 12 hours; 2. Severe hypotension or cardiogenic shock that cannot be corrected by optimized medication; 3. Successful thrombolysis ; 4. Platelet (PLT) 110 umol/L; Uric acid > 0.42mol/L; Heart rate = 24kg/m2; Male weight < 50Kg; Female weight < 40Kg; 5. History of other myocardial infarction in the past 5 weeks; 6. The condition was unable to complete PCI; 7. Pregnant and nursing women; 8. Participated in other clinical trials within the past 1 month; 9. Not suitable for participants.

Design outcomes

Secondary

Measure	Time frame
ST-segment resolution;MACE;CK, CK-M, cTnI;	—

Primary

Measure	Time frame
CTFC;	—

Countries

China

Contacts

Public ContactMin Fan

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM

fanmin@medmail.com.cn+86 13564528699

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026